Healthcare provider profile · identity verified

Martin Jay Kessler, M.D.

Family Practice · VOORHEES, NJ · NPI 1164446472

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	547	140
Amlodipine Besylate	Amlodipine Besylate	314	89
Metformin Hcl	Metformin Hcl	261	70
Lisinopril	Lisinopril	255	59
Levothyroxine Sodium	Levothyroxine Sodium	225	49
Hydrochlorothiazide	Hydrochlorothiazide	211	61
Albuterol Sulfate Hfa	Albuterol Sulfate	190	67
Furosemide	Furosemide	179	44
Omeprazole	Omeprazole	179	52
Pantoprazole Sodium	Pantoprazole Sodium	158	41
Losartan Potassium	Losartan Potassium	139	31
Gabapentin	Gabapentin	135	41
Simvastatin	Simvastatin	132	35
Metoprolol Tartrate	Metoprolol Tartrate	128	27
Fluticasone Propionate	Fluticasone Propionate	116	38
Famotidine	Famotidine	111	35
Trazodone Hcl	Trazodone Hcl	111	20
Metoprolol Succinate	Metoprolol Succinate	103	31
Triamcinolone Acetonide	Triamcinolone Acetonide	100	59
Enalapril Maleate	Enalapril Maleate	97	25
Escitalopram Oxalate	Escitalopram Oxalate	91	13
Clopidogrel	Clopidogrel Bisulfate	89	18
Hydralazine Hcl	Hydralazine Hcl	88	23
Sertraline Hcl	Sertraline Hcl	80	17
Ibuprofen	Ibuprofen	75	31
Potassium Chloride	Potassium Chloride	71	16
Montelukast Sodium	Montelukast Sodium	68	18
Eliquis	Apixaban	67	13
Fluoxetine Hcl	Fluoxetine Hcl	63	14
Rosuvastatin Calcium	Rosuvastatin Calcium	63	18
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	62	16
Carvedilol	Carvedilol	61	13
Diclofenac Sodium	Diclofenac Sodium	59	15
Pregabalin	Pregabalin	57	11
Prednisone	Prednisone	56	45
Ozempic	Semaglutide	55	12
Tramadol Hcl	Tramadol Hcl	54	17
Doxycycline Hyclate	Doxycycline Hyclate	52	51
Naproxen	Naproxen	52	20
Pravastatin Sodium	Pravastatin Sodium	51	16
Glimepiride	Glimepiride	50	16
Alprazolam	Alprazolam	48	12
Cefuroxime	Cefuroxime Axetil	46	46
Duloxetine Hcl	Duloxetine Hcl	46	12
Meloxicam	Meloxicam	46	11
Tamsulosin Hcl	Tamsulosin Hcl	46	14
Jardiance	Empagliflozin	42	11
Tizanidine Hcl	Tizanidine Hcl	41	suppressed
Clonazepam	Clonazepam	40	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	suppressed
Meclizine Hcl	Meclizine Hcl	38	suppressed
Fenofibrate	Fenofibrate	37	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	suppressed
Atenolol	Atenolol	35	suppressed
Allopurinol	Allopurinol	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	29
Glipizide	Glipizide	31	suppressed
Nifedipine Er	Nifedipine	30	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	30	30
Mupirocin	Mupirocin	29	25
Clotrimazole	Clotrimazole	28	18
Ezetimibe	Ezetimibe	28	suppressed
Lorazepam	Lorazepam	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	25	11
Mirtazapine	Mirtazapine	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Baclofen	Baclofen	24	suppressed
Methylprednisolone	Methylprednisolone	24	11
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Celecoxib	Celecoxib	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Varenicline Tartrate	Varenicline Tartrate	23	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Valsartan	Valsartan	22	suppressed
Azithromycin	Azithromycin	21	21
Buspirone Hcl	Buspirone Hcl	21	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Amoxicillin	Amoxicillin	20	20
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Ramipril	Ramipril	20	suppressed
Bydureon Bcise	Exenatide Microspheres	19	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	19
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Nortrel	Norethindrone-Ethin. Estradiol	13	suppressed
Nyamyc	Nystatin	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Victoza 3-Pak	Liraglutide	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Linzess	Linaclotide	11	suppressed
Ofloxacin	Ofloxacin	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error